Bevacizumab in mCRC: Mounting Evidence of BenefitBevacizumab in mCRC: Mounting Evidence of Benefit

Dr. Alok Khorana discusses a randomized trial indicating that bevacizumab added to standard chemotherapy after first progression in metastatic colorectal disease improves survival. Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Viewpoint Source Type: news